Target intelligence / Profile preview

Nuclear receptor binding SET domain protein 2 (NSD2) PWWP1 domain (NSD2-PWWP1)

Target
NSD2-PWWP1
Molecular classification
Histone modification, Enzyme, Transcription factor, Other
01

Overview

Nuclear receptor binding SET domain protein 2 (NSD2), also known as MMSET or WHSC1, is a histone lysine methyltransferase responsible for the global mono- and dimethylation of lysine 36 on histone H3 (H3K36) [4, 6]. The PWWP1 domain is a critical N-terminal reader module that recognizes H3K36me2 and H3K36me3 marks, anchoring the enzyme to chromatin to facilitate the propagation of epigenetic states [1, 13]. Dysregulation of NSD2, frequently occurring via the t(4;14) translocation in multiple myeloma or hyper-activating mutations like E1099K in pediatric acute lymphoblastic leukemia, leads to aberrant gene expression programs and accelerated cell proliferation [10, 16]. Pharmacological targeting of the NSD2-PWWP1 domain using selective antagonists such as the chemical probe UNC6934 disrupts its interaction with methylated nucleosomes [5, 17]. This antagonism induces the mislocalization of NSD2 to the nucleolus and inhibits its ability to drive oncogenic transcriptional profiles, offering a promising therapeutic strategy where catalytic SET domain inhibition has proven challenging [6, 8].

Other names
MMSET PWWP1 domainWHSC1 PWWP1 domainKMT3G PWWP1 domainWolf-Hirschhorn syndrome candidate 1 PWWP1Multiple myeloma SET domain PWWP1Histone-lysine N-methyltransferase NSD2 PWWP1 domain
02

Mechanism of action

Small-molecule antagonists bind to the conserved aromatic cage of the PWWP1 domain, competitively blocking its recognition of dimethylated H3K36 (H3K36me2) and nucleosomal DNA, which causes the NSD2 protein to disengage from chromatin and mislocalize to the nucleolus [5, 17].

03

Biological functions

Chromatin bindingCell proliferationEpigenetic regulationGene transcriptionDNA repairHistone methylation
04

Disease associations

CancerMultiple MyelomaAcute Lymphoblastic LeukemiaWolf-Hirschhorn syndromeLung cancerProstate cancer
05

Safety considerations

Potential for Wolf-Hirschhorn syndrome-like developmental defects from systemic inhibitionDisruption of normal B-cell development and immune functionNucleolar stress and accumulation due to protein mislocalization
06

Interacting drugs

UNC6934

5 more in the full profile.

07

Biomarkers

H3K36me2 global levelst(4;14) chromosomal translocationE1099K activating mutation

Beyond the preview

Go deeper on Nuclear receptor binding SET domain protein 2 (NSD2) PWWP1 domain (NSD2-PWWP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear receptor binding SET domain protein 2 (NSD2) PWWP1 domain (NSD2-PWWP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call